MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$2,690,887
EPS
-$0.17
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-09-30
2025-06-30
2025-03-31
Net revenues
-
-
0
-
Research and development expense
1,519,002
1,633,476
1,039,713
1,958,602
General and administrative expenses
1,129,447
2,447,188
1,159,936
1,517,415
Total operating expenses
2,648,449
4,080,664
2,199,649
3,476,017
Loss from operations
-2,648,449
-4,080,664
-2,199,649
-3,476,017
Unrealized loss on crypto assets
-
25,305
-
-
Realized loss on crypto assets
44,165
-
-
-
Dividend and interest income
149
168
173
181
Change in fair value of investment in joint ventures
-
-
0
-
Total other income (expenses), net
-44,016
-25,137
173
181
Net loss
-2,692,465
-4,105,801
-2,199,476
-3,475,836
Foreign currency translation adjustment
1,578
-1,016
3,478
-497
Total comprehensive loss
-2,690,887
-4,106,817
-2,195,998
-3,476,333
Basic EPS
-0.17
-0.3
-0.17
-0.27
Diluted EPS
-0.17
-0.3
-0.17
-0.27
Basic Average Shares
15,792,337
13,787,159
13,180,243
12,727,581
Diluted Average Shares
15,792,337
13,787,159
13,180,243
12,727,581
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Total comprehensive
loss
-$2,690,887
(22.59%↑ Y/Y)
Foreign currency
translation adjustment
$1,578
(417.51%↑ Y/Y)
Net loss
-$2,692,465
(22.54%↑ Y/Y)
Loss from operations
-$2,648,449
(23.81%↑ Y/Y)
Total other income
(expenses), net
-$44,016
(-24418.23%↓ Y/Y)
Dividend and interest
income
$149
(-17.68%↓ Y/Y)
Total operating
expenses
$2,648,449
(-23.81%↓ Y/Y)
Realized loss on crypto
assets
$44,165
Research and development
expense
$1,519,002
(-22.44%↓ Y/Y)
General and
administrative expenses
$1,129,447
(-25.57%↓ Y/Y)
Buy us a coffee
Hoth Therapeutics, Inc. (HOTH)
Hoth Therapeutics, Inc. (HOTH)